…of the remarkable STAR Biotech Alliance Partners with whom we collaborate to advance research for CMT. Support CMT Research View the projects currently active or recently completed in the CMT2A…
…independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF employs over 45 researchers at the NYSCF Research Institute, located in New…
…two mutations in the SH3TC2 gene. (If you would like more information and advanced descriptions about CMT types please go to the Rare Diseases Clinical Research Network (RDCRN) to learn…
…the remarkable STAR Biotech Alliance Partners with whom we collaborate to advance research for CMT. DONATE TO STAR RESEARCH CMT1A RESEARCH PROJECTS PROJECT GOAL: TO DEVELOP NEW CELL-BASED DISEASE MODELS…
…to advance research for CMT. Support CMT Research View the projects currently active or recently completed in the CMT4 drug development pipeline. CMT4 RESEARCH PROJECTS CMT4A Research CMT Type 4A…
…Stem Cell Foundation (NYSCF) Research Institute is an independent organization accelerating cures and better treatments for patients through stem cell research. The NYSCF Research Institute employs over 45 researchers in…
…Partners with whom we collaborate to advance research for CMT. Support CMT Research View the projects currently active or recently completed in the CMT2E drug development pipeline. CMT2E RESEARCH PROJECTS…
…made enormous strides in the organization as a whole and in the research area in particular. As new leadership unfolded at the organization, new ideas for research blossomed. The “STAR…
…of upcoming clinical trials. CMTA-STAR OVERVIEW AND RESEARCH UPDATE This is an in-depth STAR research update led by CMTA Board Chair Gilles Bouchard and accompanied by CMT scientists and researchers…